Coronavirus
Total 205 Posts
Coronaviruses are a family of viruses that can cause various illnesses ranging from the common cold to more severe diseases. The coronavirus that has been recently discovered causes a condition called COVID-19. The new coronavirus outbreak began in Wuhan, China, in December 2019. COVID-2019 can be transmitted through contact with respiratory droplets.
Νέα έρευνα σε εξωτερικούς ασθενείς αποκαλύπτει ότι ο συνδυασμός Ψευδάργυρου, Υδροξυχλωροκινης, και αζιθρομυκίνης σχετίζεται με μειωμένες νοσηλείες και θανάτους σε ασθενείς με COVID-19
Η μελέτη αναφέρει ένα πολύ χαμηλό ποσοστό θνησιμότητας 0,71% σε ασθενείς που έλαβαν θεραπεία με επιβεβαιωμένα θετικά κρούσματα COVID-19.
Aimsíonn StaidéAR Othar Seachtrach Nua-Fhoilsithe Go Bhfuil Comhgléas Sinc, Hydroxychloroquine Agus Azithromycin Bainteach Le NíOS Lú Cur San Ospidéal Agus Báis in Othair COVID-19
Tuairiscíonn an staidéar ráta báis an-íseal de 0.71% in othair chóireáilte le cásanna dearfacha dearbhaithe de COVID-19.
Utafiti Mpya Uliochapishwa Hivi Karibuni Hugundua Kuwa Mchanganyiko WA Zinc, Hdroxychloroquine, NA Azithromycin Unahusishwa NA Hospitali NA Vifo Kidogo Katika Wagonjwa WA Covid-19
Utafiti unaripoti kiwango cha chini kabisa cha vifo vya asilimia 0.71% kwa wagonjwa waliotibiwa walio na kesi chanya za COVID-19.
Un Studiu îN Ambulatoriu Recent Publicat Arată Că O CombinațIe DE Zinc, Hidroxiclorochină șI Azitromicină Este Asociată CU O SCăDere a SpitalizăRilor șI Deceselor La PaciențII CU Covid-19
Studiul raportează o rată de fatalitate foarte scăzută de 0,71% la pacienții tratați cu cazuri pozitive confirmate de COVID-19.
An Urgent Appeal to Pray for Dr. Vladimir Zelenko: Details of His Illness
Two years ago, Dr. Zelenko faced a rare disease, but he made a treatment plan with his doctor and recovered. Unfortunately, during the latest CAT scan, another problem was found.
Six More Studies Confirm That Early Treatment Using Dr. Zelenko’s Protocol Reduces Mortality Rates of COVID-19 Patients
All six studies showed that HCQ, given early in the course of the COVID-19 disease, alone or in combination with zinc and azithromycin, reduced hospital admissions and mortality without serious heart problems or other adverse effects.
신규 발표된 외래환자 연구결과에서 아연, 하이드록시클로로퀸과 아지트로마이신의 조합이 COVID-19 환자에서 입원율 및 사망율의 감소와 관련이 있음을 발견
이 연구는 COVID-19의 양성 사례가 확인 된 치료 환자에서 0.71 %의 매우 낮은 사망률을보고합니다.
